Clinical study comparing treatment effects against an inactive substance to measure true efficacy
A placebo-controlled trial is a clinical study in which one group of participants receives the treatment being tested while another group receives an inactive substance (placebo) or sham procedure. By comparing outcomes between the two groups, researchers can determine whether the treatment has an effect beyond the psychological impact of receiving care — the placebo effect.
Placebo-controlled trials are considered the gold standard of evidence-based medicine. However, the design and conduct of these trials are vulnerable to manipulation. Pharmaceutical companies funding their own trials have been documented using selective outcome reporting (publishing positive results while burying negative ones), choosing comparators that make their product look better, designing trials with endpoints favorable to their product, and terminating trials early when interim results look positive.
The integrity of placebo-controlled trials depends on blinding (neither participants nor researchers know who receives the real treatment), randomization, adequate sample sizes, and transparent reporting of all outcomes. When any of these elements is compromised — whether through incompetence or deliberate manipulation — the results become unreliable, potentially leading to the approval of drugs that are less effective or more dangerous than the trial data suggests.
